These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32991933)

  • 1. Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
    Pol S; Liang S; Schweser F; Dhanraj R; Schubart A; Preda M; Sveinsson M; Ramasamy DP; Dwyer MG; Weckbecker G; Zivadinov R
    Exp Neurol; 2021 Jan; 335():113488. PubMed ID: 32991933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis.
    Kap YS; Bauer J; Driel Nv; Bleeker WK; Parren PW; Kooi EJ; Geurts JJ; Laman JD; Craigen JL; Blezer E; 't Hart BA
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):992-1005. PubMed ID: 22002426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
    Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
    Front Immunol; 2019; 10():2437. PubMed ID: 31681317
    [No Abstract]   [Full Text] [Related]  

  • 4. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
    Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
    Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell depletion abrogates T cell-mediated demyelination in an antibody-nondependent common marmoset experimental autoimmune encephalomyelitis model.
    Jagessar SA; Heijmans N; Bauer J; Blezer EL; Laman JD; Hellings N; 't Hart BA
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):716-28. PubMed ID: 22805775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.
    Lehmann-Horn K; Schleich E; Hertzenberg D; Hapfelmeier A; Kümpfel T; von Bubnoff N; Hohlfeld R; Berthele A; Hemmer B; Weber MS
    J Neuroinflammation; 2011 Oct; 8():146. PubMed ID: 22027448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity.
    Gupta S; Simic M; Sagan SA; Shepherd C; Duecker J; Sobel RA; Dandekar R; Wu GF; Wu W; Pak JE; Hauser SL; Lim W; Wilson MR; Zamvil SS
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36657993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
    Martinez-Pasamar S; Abad E; Moreno B; Velez de Mendizabal N; Martinez-Forero I; Garcia-Ojalvo J; Villoslada P
    BMC Syst Biol; 2013 Apr; 7():34. PubMed ID: 23618467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS.
    Kumar G; Maria Z; Kohli U; Agasing A; Quinn JL; Ko RM; Zamvil SS; Axtell RC
    Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33649164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
    Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
    J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets.
    Kap YS; van Driel N; Blezer E; Parren PW; Bleeker WK; Laman JD; Craigen JL; 't Hart BA
    J Immunol; 2010 Oct; 185(7):3990-4003. PubMed ID: 20739677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.
    Häusler D; Häusser-Kinzel S; Feldmann L; Torke S; Lepennetier G; Bernard CCA; Zamvil SS; Brück W; Lehmann-Horn K; Weber MS
    Proc Natl Acad Sci U S A; 2018 Sep; 115(39):9773-9778. PubMed ID: 30194232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis.
    Carnasciali A; Amoriello R; Bonechi E; Mazzoni A; Ravagli C; Doumett S; Cappiello L; D'Elios MM; Baldi G; Ballerini C
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):376-389. PubMed ID: 32514635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis.
    Meyer CE; Gao JL; Cheng JY; Oberoi MR; Johnsonbaugh H; Lepore S; Kurth F; Thurston MJ; Itoh N; Patel KR; Voskuhl RR; MacKenzie-Graham A
    Mult Scler; 2020 Mar; 26(3):294-303. PubMed ID: 30843756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.
    Yin JJ; Hu XQ; Mao ZF; Bao J; Qiu W; Lu ZQ; Wu HT; Zhong XN
    Chin Med J (Engl); 2017 Apr; 130(8):964-971. PubMed ID: 28397727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis.
    Tacke S; Chunder R; Schropp V; Urich E; Kuerten S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis.
    Sefia E; Pryce G; Meier UC; Giovannoni G; Baker D
    Mult Scler Relat Disord; 2017 May; 14():46-50. PubMed ID: 28619431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.